According to TechSci Research report, “Global Hydroxychloroquine
and Chloroquine Market By Type, By Route of Administration,
By Strength, By Application, By Region, Competition, Forecast & Opportunities,
2030”, the global
hydroxychloroquine and chloroquine market is projected to reach $ 285 million
in 2020, predominantly on account of rising use of the drug in treating novel
coronavirus COVID-19. Though, it has not been proven clinically that the drug
can be used in treating coronavirus, but it has been identified that the drug
is helpful in improving the early symptoms of the disease, especially the
respiratory problems. Globally,
Ipca and Cadila are among the top manufacturers of these drugs.
Browse
161 market data Figures spread through more than 110 Pages and an
in-depth TOC on"Global Hydroxychloroquine and Chloroquine
Market"
The global
hydroxychloroquine and chloroquine market are segmented based on type, route of
administration, strength, application and region. Based on type, the market can
be categorized into injectables and tablets. The tablets segment is expected to
dominate the market during the forecast period since these are cost effective.
Based on route of administration, the market can be bifurcated into oral and
intravenous. The oral segment is expected to dominate the market since the drug
is generally consumed orally in the form of tablets. Based on application, the
market can be categorized into rheumatoid arthritis, malaria, COVID-19 and others. The
COVID-19 segment is expected to register the highest growth during forecast
period since it has been identified that the drug can be used to treat the
disease, though not clinically proven. Additionally, studies suggest that it is
helpful in treating some symptoms of the disease and is being used widely in
the treatment guidelines of COVID-19. Countries such as China, South Korea and
Belgium have added hydroxychloroquine and chloroquine in their coronavirus
disease treatment guidelines. Also, studies suggest that the drug has been
helpful in treating few cases of the disease in France. Due to rising spread of
the pandemic, FDA issued an Emergency Use Authorization for the treatment of
novel coronavirus disease (COVID-19). Ipca Laboratories
Ltd, Zydus Cadila, Novartis AG, Teva Pharmaceutical Industries Ltd., Bayer
AG, Rising Pharma Holdings Inc, Abcam plc, Mylan N.V, and Abbott are some of
the leading players operating in global chloroquine market.
Customers can also request for 10% free customization on
this report.
“North
America is expected to register significant growth in the
hydroxychloroquine and chloroquine market during the forecast period, owing to
the use of drug for treating COVID-19. Additionally, the drug is being used in
the coronavirus treatment guidelines in various other countries. If it gets
proven clinically that the drug can be used for the treatment of COVID-19, then
this is expected to create lucrative opportunities for the market players in
foreseeable future.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global Hydroxychloroquine and Chloroquine Market By Type,
By Route of Administration, By Strength, By Application, By Region,
Competition, Forecast & Opportunities, 2030” has evaluated
the future growth potential of global hydroxychloroquine and chloroquine market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global hydroxychloroquine and chloroquine
market.
Browse Related Reports
United States Regenerative Medicine Market By Type (Cell-based
immunotherapy & Cell therapy products, Gene therapy products,
Tissue-engineered products, Others), By Material (Biologically Derived
Material, Synthetic Material, Pharmaceuticals, Genetically Engineered Material,
Others), By Application (Musculoskeletal Disorders, Wound Care, Oncology,
Ocular Disorders, Diabetes, Others), By Region, Forecast & Opportunities,
2025
Global Leukemia Therapeutics Market By
Factor (Artificial ionizing radiation, Viruses, Others), By Severity (Acute,
Chronic), By Blood Cell (Lymphocytic, Myelogenous), By Age Groups (0-15, 15-30,
30-50, 50+), By Sex (Male, Female), By Treatment (Targeted Therapy, Interferon
Therapy, Radiation Therapy, Others), By Diagnosis (Blood test, Biopsy, Physical
Exam, Imagining), By Route of Administration (Oral, Intravenous, Subcutaneous,
Intramuscular, Intrathecal), By Drugs (Antimetabolites, Biosimilars, Others), By
Region, Forecast & Opportunities, 2025
No comments:
Post a Comment